Oyster Point Pharma Inc. (OYST) to be Acquired by Viatris (VTRS) for $11 Per Share Plus CVR Nov 7, 2022 08:02AM
Oyster Point Pharma, a Leading Ophthalmology-Focused Biopharmaceutical Company, to be Acquired by Viatris Nov 7, 2022 08:00AM
Oyster Point Pharma, a Leading Ophthalmology-Focused Biopharmaceutical Company, to be Acquired by Viatris Nov 7, 2022 08:00AM